Last week, the Food and Drug Administration (FDA) responded to calls from our community to reconsider its role in regulating gene editing technology in animal agriculture. Despite the Trump administration’s recent directive to streamline costly and overly burdensome regulations that inhibit innovation and investment, FDA maintains it is unwilling to cede any regulatory control of this important technology.
Read More
